Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep151 | Calcium and Bone | ECE2023

Evaluation of the efficacy and safety of long-term Cinacalcet in primary hyperparathyroidism

Huguet Isabel , Timon Iciar Martin , Moreno-Ruiz Inmaculada , Yannuzzi Vanessa Trivino , Llavero Maria , Meizoso-Pita Olalla , Gargallo Fernandez Manuel Angel , Sevillano-Collantes Cristina

Introduction: Cinacalcet is a positive allosteric modulator of the calcium sensing receptor successfully used to decrease serum calcium in primary hyperparathyroidism (pHPT) patients in the short-term, but long-term data are scarce. In this single-centre retrospective analysis, we investigated the efficacy and safety of cinacalcet in pHPT patients who received more than 5 years of treatment.Methods: Statistical analysis was performed using free online so...

ea0049gp198 | Thyroid 1 | ECE2017

Which is the best tool to use when initiating the differential diagnosis of a thyrotoxic patient? A challenge to current guideline recommendations

Perdomo Carolina , Ramos Elisa Gil , Buey Gala Gutierrez , Llavero Maria , Gargallo Javier , Arbizu Javier , de la Higuera Magdalena , Galofre Juan C

Aim: Differential diagnosis (DD) of thyrotoxicosis is critical as the treatment of the three main causes of this condition (GravesÂ’ disease [GD], Toxic Multinodular Goitre [TMG], and Thyroiditis [TS]) differs substantially. Recently published diagnostic algorithms investigating hyperthyroidism embrace the presence of thyrotropin receptor (TSH-R) antibodies (TRab) as the first and most cruicial diagnostic step. Although TRab measurement has important limitations (some can ...

ea0049ep227 | Bone & Osteoporosis | ECE2017

Bone remodeling markers predict bone loss in premenopausal women

Buey Gala Gutierrez , Botella Sonsoles , Restituto Patricia , Fraile Macarena Rodriguez , Calleja Amparo , Llavero Maria , Gargallo Javier , Perdomo Carolina , Andrada Patricia , Varo Nerea , Galofre Juan C

Aim: Bone turnover markers (BTMs) predict more rapid rates of bone loss. However, most of these studies have been carried out in postmenopausal women. Few prospective studies have examined the degradation marker C-terminal telopeptide of type I collagen (CTX) and the bone formation marker N-aminoterminal propeptide of type I collagen (P1NP) measured during the menopausal transition to predict the subsequent bone loss.Methods: We performed a prospective c...

ea0056gp74 | Diabetes Complications | ECE2018

Is liver stiffness associated with diabetic complications in patients with type 2 diabetes and non-alcoholic fatty liver disease?

Perdomo Carolina M , Gargallo Javier , Llavero Maria , Garcia Marta , Bojorquez Alejandro , Inarrairaegui Mercedes , Herrero Jose I , Silva Camilo , Fruhbeck Gema , Salvador Javier , Escalada Javier

Aim: Non-alcoholic fatty liver disease (NAFLD) and type 2 Diabetes (T2D) are common conditions that frequently co-exist. Studies have shown an increase likelihood of micro and macrovascular complications in this population, as well, as an increased risk of developing more severe forms of liver disease. The aim of this study was to identify diabetic complications in patients with both diseases and search for an association with liver stiffness assessed by Liver Elastography (LE...

ea0056p595 | Obesity | ECE2018

The preoperative diagnosis of type 2 diabetes in the absence of antidiabetic treatment is associated with a worse performance after gastric-bypass compared to patients without diabetes

Gargallo Javier , Laguna Sara , Llavero Maria , Perdomo Carolina M , Valenti Victor , Escalada Javier , Gomez-Ambrosi Javier , Silva Camilo , Fruhbeck Gema , Salvador Javier

Objectives and methods: The mechanism that explains the different weight response to various treatments in obese type 2 diabetes (DM2) patients, compared to those without diabetes, is still unknown. In order to establish the weight response to Roux-en-Y Gastric Bypass (RYGB), 268 patients with morbid obesity (IMC 45.4±0.4 kg/m2) were classified by OGTT as having normal glucose tolerance (Grupo A. n=107), prediabetes (Grupo B. n=96) an...

ea0056p1048 | Thyroid (non-cancer) | ECE2018

Correlation of recommended diagnostic tools with pathological findings in the thyrotoxic patient

Perdomo Carolina M , Paricio Jose Joaquin , Llavero Maria , Gargallo Javier , Garcia Marta , Miralles Raquel , Morales Maria I , Alcalde Juan , Idoate Miguel Angel , Arbizu Javier , Galofre Juan C

Aim: A key diagnostic step to determine the cause of hyperthyroidism is the measurement of circulating thyroid-stimulating immunoglobulin (TSI). High levels are associated with GravesÂ’ disease (GD). A thyroid scintigraphy (TRS) is recommended when TSI is absent or its measurement unavailable, as TRS is capable of differentiating between GD (diffuse uptake) and toxic goitre (TG) (patchy uptake). Nevertheless, and while rarely necessary, histopathology remain the best metho...

ea0056p1170 | Thyroid cancer | ECE2018

Evolution of tumor markers after external beam radiotherapy in the non-undifferentiated thyroid cancer

Moragrega Raquel Miralles , Freixes Maria Maria Curras , Zelaya Carolina Perdomo , Vaamonde Javier Gargallo , Valero Maria Llavero , Jimenez Marta Moreno , Galofre Juan C

Introduction: The role of external beam radiotherapy (EBRT) as primary or as adjuvant therapy in the non-undifferentiated thyroid cancer (NUTC) is controversial. Most published data refer to retrospective case series. Therefore, little is known about the correlation between tumor markers and radiologic measurements of tumor response.Objectives: The study aimed to analyze the kinetics of tumor markers and radiologic measurement of tumor response after EBR...

ea0063p529 | Diabetes, Obesity and Metabolism 2 | ECE2019

Epicardial fat accumulation in non-alcoholic liver disease and impaired glucose metabolism

Zelaya Carolina Maria Perdomo , Vaamonde Javier Gargallo , Goni Marta Garcia , Cardenas Juana Karina Zapata , Kollozi Ina , Valero Maria Llavero , Santos Jose Ignacio Herrero , Aleman Gorka Bastarrika , Martin Francisco Javier Escalada San

Patients with impaired glucose metabolism, either prediabetes (preD) or type 2 Diabetes (T2D), and non-alcoholic fatty liver disease (NAFLD) have a higher prevalence of cardiovascular events. Recent studies have shown a relationship between epicardial fat and myocardial ischemia.Objective: To determine whether hepatic fibrosis assessed by liver elastography (LE) or Fibrosis-4 (FIB-4) score correlates with epicardial fat volume quantified by computed tomo...